Effect of Scopolamine Butylbromide on Clozapine-induced Hypersalivation in Schizophrenic Patients: A Case Series

Clozapine has been demonstrated to be useful for treating refractory schizophrenia. However, hypersalivation occurs in 31.0–97.4% of the patients treated with clozapine. Accordingly, some patients who are disturbed by their hypersalivation refuse to continue with clozapine treatment. This study inve...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Psychopharmacol Neurosci
Main Authors: Takeuchi, Ippei, Suzuki, Tatsuyo, Kishi, Taro, Kanamori, Daisuke, Hanya, Manako, Uno, Junji, Fujita, Kiyoshi, Kamei, Hiroyuki
Formato: Artigo
Idioma:Inglês
Publicado: Korean College of Neuropsychopharmacology 2015
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4423163/
https://ncbi.nlm.nih.gov/pubmed/25912544
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9758/cpn.2015.13.1.109
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares